1. Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors

   • Hiroyuki Kobayashi
   • S. Gail Eckhardt
   • Michele L. Basche

   Original Article 20 May 2005 Pages: 329 - 336

   

2. Platinum-acridinylthiourea conjugates show cell line-specific cytotoxic enhancement in H460 lung carcinoma cells compared to cisplatin

   • Suzanne M. Hess
   • Amanda M. Mounce
   • Ulrich Bierbach

   Original Article 13 May 2005 Pages: 337 - 343

   

3. Absence of N-linked glycosylation does not affect plasma membrane localization of breast cancer resistance protein (BCRP/ABCG2)

   • Karin Mohrmann
   • Maria A. J. van Eijndhoven
   • Jan H. M. Schellens

   Original Article 05 May 2005 Pages: 344 - 350

   

4. Metabolic profile of XK469 (2(R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug–drug interactions

   • Lawrence W. Anderson
   • Jerry M. Collins
   • S. Percy Ivy

   Original Article 13 May 2005 Pages: 351 - 357

   

5. Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study

   • Periklis Pappas
   • Vasilis Karavasilis
   • Marios Marselos

   Original Article 10 May 2005 Pages: 358 - 360

   

6. Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancer

   • Rene Bruno
   • Carla B. Washington
   • Pamela Klein

   Original Article 03 May 2005 Pages: 361 - 369

   

7. Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism

   • Milly E. de Jonge
   • Alwin D. R. Huitema
   • Sjoerd Rodenhuis

   Original Article 19 April 2005 Pages: 370 - 378

   

8. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice

   • Ting-Chao Chou
   • Yongbiao Guan
   • Dale L. Boger

   Original Article 04 May 2005 Pages: 379 - 390

   

9. Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss

   • SMF Jamieson
   • J Liu
   • MJ McKeage

   Original Article 11 May 2005 Pages: 391 - 399

   

10. Peroxisome proliferator activated receptor-γ ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells

    • Jiajun Liu
    • Huiling Lu
    • Feng Chen

    Original Article 19 April 2005 Pages: 400 - 408

    

11. Identification of biliary metabolites of ifosfamide using ³¹P magnetic resonance spectroscopy and mass spectrometry

    • Geoffrey S Payne
    • Andrzej SK Dzik-Jurasz
    • Martin O Leach

    Original Article 05 May 2005 Pages: 409 - 414

    

12. Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer

    • Francesco Boccardo
    • Alessandra Rubagotti
    • Demetrio Del Monaco

    Original Article 19 April 2005 Pages: 415 - 420

13. Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer

    • Apurva A. Desai
    • Hedy L. Kindler
    • Everett E. Vokes

    Original Article 13 May 2005 Pages: 421 - 426

14. Neoadjuvant chemotherapy for epithelial ovarian cancer—role of apoptosis

    • Tania Dutta
    • Himani Sharma
    • Neeta Singh

    Original Article 19 May 2005 Pages: 427 - 435

    

15. Antiangiogenic and antitumoral properties of a polysaccharide isolated from the seaweed Sargassum stenophyllum

    • Paulo Fernando Dias
    • Jarbas Mota Siqueira Jr
    • Rosa Maria Ribeiro-do-Valle

    Original Article 18 May 2005 Pages: 436 - 446